Amy Krafft is a program officer in the influenza program in the National Institute of Allergies and Infectious Diseases (NIAID), part of the NIH. She oversees a portfolio of grants for discovery, translational science and early preclinical development of influenza therapeutics and diagnostics. She also provides technical oversight for contracts providing proof-of-concept studies for evaluation of new antiviral candidates in vitro and in mouse models to the research community. Prior to her administrative role at NIAID, she worked in several clinical laboratories for more than 15 years in urban pediatric and adult hospitals and also anatomic pathology laboratories at the Armed Forces Institutes of Pathology (AFIP) where she designed and developed molecular diagnostics assays used in hematopathology, solid tumor, and infectious diseases consultations and also influenza and adenovirus assays as part of a Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS) project. She has served as the Scientific Director of the Molecular Diagnostics Laboratory at the AFIP and taught classes in undergraduate and graduate schools for several years, serving as an adjunct professor of Vaccine Development and Epidemiology of Emerging Infectious Diseases at the University of Maryland University College and a lecturer on Laboratory Aspects of Biowarfare in annual Policy courses at the Uniformed Services University of Health Sciences and the Johns Hopkins School of Public Health. She received her undergraduate training at Mary Washington College in Biology and Economics, Medical Technology certification at the Catholic University of America, and a Doctorate in Microbiology and Immunology from the Medical College of Virginia.